NEPHROS INC (NEPH) Fundamental Analysis & Valuation

NASDAQ:NEPH • US6406714005

Current stock price

2.825 USD
-0.06 (-2.25%)
Last:

This NEPH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NEPH Profitability Analysis

1.1 Basic Checks

  • In the past year NEPH was profitable.
  • In the past year NEPH had a positive cash flow from operations.
  • In multiple years NEPH reported negative net income over the last 5 years.
  • In multiple years NEPH reported negative operating cash flow during the last 5 years.
NEPH Yearly Net Income VS EBIT VS OCF VS FCFNEPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M

1.2 Ratios

  • The Return On Assets of NEPH (8.75%) is better than 76.34% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.70%, NEPH is in the better half of the industry, outperforming 64.89% of the companies in the same industry.
  • NEPH has a better Return On Invested Capital (9.60%) than 70.23% of its industry peers.
Industry RankSector Rank
ROA 8.75%
ROE 11.7%
ROIC 9.6%
ROA(3y)-1.29%
ROA(5y)-18.85%
ROE(3y)-2.09%
ROE(5y)-34.69%
ROIC(3y)N/A
ROIC(5y)N/A
NEPH Yearly ROA, ROE, ROICNEPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • NEPH has a Profit Margin of 6.35%. This is comparable to the rest of the industry: NEPH outperforms 55.73% of its industry peers.
  • NEPH has a Operating Margin (6.10%) which is comparable to the rest of the industry.
  • Looking at the Gross Margin, with a value of 61.87%, NEPH belongs to the top of the industry, outperforming 99.24% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NEPH has grown nicely.
Industry RankSector Rank
OM 6.1%
PM (TTM) 6.35%
GM 61.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.29%
GM growth 5Y1.53%
NEPH Yearly Profit, Operating, Gross MarginsNEPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NEPH Health Analysis

2.1 Basic Checks

  • NEPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NEPH has more shares outstanding than it did 1 year ago.
  • NEPH has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NEPH has an improved debt to assets ratio.
NEPH Yearly Shares OutstandingNEPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
NEPH Yearly Total Debt VS Total AssetsNEPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • NEPH has an Altman-Z score of -7.05. This is a bad value and indicates that NEPH is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -7.05, NEPH is not doing good in the industry: 90.08% of the companies in the same industry are doing better.
  • NEPH has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.01, NEPH belongs to the best of the industry, outperforming 93.89% of the companies in the same industry.
  • NEPH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • NEPH has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. NEPH outperforms 85.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z -7.05
ROIC/WACC0.94
WACC10.23%
NEPH Yearly LT Debt VS Equity VS FCFNEPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 4.06 indicates that NEPH has no problem at all paying its short term obligations.
  • NEPH has a better Current ratio (4.06) than 87.02% of its industry peers.
  • A Quick Ratio of 2.89 indicates that NEPH has no problem at all paying its short term obligations.
  • NEPH's Quick ratio of 2.89 is amongst the best of the industry. NEPH outperforms 87.02% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 2.89
NEPH Yearly Current Assets VS Current LiabilitesNEPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NEPH Growth Analysis

3.1 Past

  • NEPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 5188146770730811392.00%, which is quite impressive.
  • Looking at the last year, NEPH shows a very strong growth in Revenue. The Revenue has grown by 32.67%.
  • NEPH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.03% yearly.
EPS 1Y (TTM)5188146770730811000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)32.67%
Revenue growth 3Y23.48%
Revenue growth 5Y17.03%
Sales Q2Q%22.2%

3.2 Future

  • Based on estimates for the next years, NEPH will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.09% on average per year.
  • Based on estimates for the next years, NEPH will show a quite strong growth in Revenue. The Revenue will grow by 11.14% on average per year.
EPS Next Y-15%
EPS Next 2Y9.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.69%
Revenue Next 2Y11.14%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NEPH Yearly Revenue VS EstimatesNEPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
NEPH Yearly EPS VS EstimatesNEPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. NEPH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 15.69, the valuation of NEPH can be described as correct.
  • Based on the Price/Earnings ratio, NEPH is valued cheaply inside the industry as 81.68% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of NEPH to the average of the S&P500 Index (24.75), we can say NEPH is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 18.46, the valuation of NEPH can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, NEPH is valued a bit cheaper than the industry average as 60.31% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, NEPH is valued at the same level.
Industry RankSector Rank
PE 15.69
Fwd PE 18.46
NEPH Price Earnings VS Forward Price EarningsNEPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NEPH is valued a bit more expensive than 63.36% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, NEPH is valued a bit cheaper than 75.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.27
EV/EBITDA 19.2
NEPH Per share dataNEPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.09%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEPH Dividend Analysis

5.1 Amount

  • No dividends for NEPH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEPH Fundamentals: All Metrics, Ratios and Statistics

NEPHROS INC

NASDAQ:NEPH (3/30/2026, 8:20:36 PM)

2.825

-0.06 (-2.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-12
Earnings (Next)05-06
Inst Owners49.91%
Inst Owner Change5.29%
Ins Owners10.85%
Ins Owner Change8.86%
Market Cap30.06M
Revenue(TTM)18.79M
Net Income(TTM)1.19M
Analysts82.5
Price Target7.14 (152.74%)
Short Float %0.06%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)465.69%
Min EPS beat(2)247.06%
Max EPS beat(2)684.31%
EPS beat(4)4
Avg EPS beat(4)547.55%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)7
Avg EPS beat(8)329.9%
EPS beat(12)9
Avg EPS beat(12)212.95%
EPS beat(16)10
Avg EPS beat(16)141.45%
Revenue beat(2)2
Avg Revenue beat(2)12.48%
Min Revenue beat(2)4.16%
Max Revenue beat(2)20.79%
Revenue beat(4)4
Avg Revenue beat(4)18.64%
Min Revenue beat(4)4.16%
Max Revenue beat(4)30.93%
Revenue beat(8)5
Avg Revenue beat(8)6.81%
Revenue beat(12)7
Avg Revenue beat(12)4.82%
Revenue beat(16)8
Avg Revenue beat(16)0.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-75%
EPS NQ rev (3m)-75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-2.31%
Revenue NQ rev (3m)-2.31%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 15.69
Fwd PE 18.46
P/S 1.6
P/FCF 18.27
P/OCF 18.27
P/B 2.95
P/tB 3.35
EV/EBITDA 19.2
EPS(TTM)0.18
EY6.37%
EPS(NY)0.15
Fwd EY5.42%
FCF(TTM)0.15
FCFY5.47%
OCF(TTM)0.15
OCFY5.47%
SpS1.77
BVpS0.96
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.97
Profitability
Industry RankSector Rank
ROA 8.75%
ROE 11.7%
ROCE 10.54%
ROIC 9.6%
ROICexc 19.07%
ROICexgc 24.66%
OM 6.1%
PM (TTM) 6.35%
GM 61.87%
FCFM 8.76%
ROA(3y)-1.29%
ROA(5y)-18.85%
ROE(3y)-2.09%
ROE(5y)-34.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.29%
GM growth 5Y1.53%
F-Score7
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 1146
Cash Conversion 128.02%
Profit Quality 137.77%
Current Ratio 4.06
Quick Ratio 2.89
Altman-Z -7.05
F-Score7
WACC10.23%
ROIC/WACC0.94
Cap/Depr(3y)25.06%
Cap/Depr(5y)26.24%
Cap/Sales(3y)0.31%
Cap/Sales(5y)0.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5188146770730811000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y-15%
EPS Next 2Y9.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.67%
Revenue growth 3Y23.48%
Revenue growth 5Y17.03%
Sales Q2Q%22.2%
Revenue Next Year10.69%
Revenue Next 2Y11.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19000%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y400.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y434.35%
OCF growth 3YN/A
OCF growth 5YN/A

NEPHROS INC / NEPH Fundamental Analysis FAQ

What is the fundamental rating for NEPH stock?

ChartMill assigns a fundamental rating of 5 / 10 to NEPH.


Can you provide the valuation status for NEPHROS INC?

ChartMill assigns a valuation rating of 4 / 10 to NEPHROS INC (NEPH). This can be considered as Fairly Valued.


Can you provide the profitability details for NEPHROS INC?

NEPHROS INC (NEPH) has a profitability rating of 4 / 10.


What are the PE and PB ratios of NEPHROS INC (NEPH) stock?

The Price/Earnings (PE) ratio for NEPHROS INC (NEPH) is 15.69 and the Price/Book (PB) ratio is 2.95.


How financially healthy is NEPHROS INC?

The financial health rating of NEPHROS INC (NEPH) is 7 / 10.